507 related articles for article (PubMed ID: 16449487)
1. Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants.
Altshuler LL; Suppes T; Black DO; Nolen WA; Leverich G; Keck PE; Frye MA; Kupka R; McElroy SL; Grunze H; Kitchen CM; Post R
Am J Psychiatry; 2006 Feb; 163(2):313-5. PubMed ID: 16449487
[TBL] [Abstract][Full Text] [Related]
2. Lower Switch Rate in Depressed Patients With Bipolar II Than Bipolar I Disorder Treated Adjunctively With Second-Generation Antidepressants.
Altshuler LL; Suppes T; Black DO; Nolen WA; Leverich G; Keck PE; Frye MA; Kupka R; McElroy SL; Grunze H; Kitchen CMR; Post R
Focus (Am Psychiatr Publ); 2023 Oct; 21(4):430-433. PubMed ID: 38695005
[TBL] [Abstract][Full Text] [Related]
3. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.
Leverich GS; Altshuler LL; Frye MA; Suppes T; McElroy SL; Keck PE; Kupka RW; Denicoff KD; Nolen WA; Grunze H; Martinez MI; Post RM
Am J Psychiatry; 2006 Feb; 163(2):232-9. PubMed ID: 16449476
[TBL] [Abstract][Full Text] [Related]
4. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant-induced mania in bipolar patients: identification of risk factors.
Henry C; Sorbara F; Lacoste J; Gindre C; Leboyer M
J Clin Psychiatry; 2001 Apr; 62(4):249-55. PubMed ID: 11379838
[TBL] [Abstract][Full Text] [Related]
6. Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.
McElroy SL; Martens BE; Winstanley EL; Creech R; Malhotra S; Keck PE
J Affect Disord; 2010 Jul; 124(1-2):157-63. PubMed ID: 19963274
[TBL] [Abstract][Full Text] [Related]
7. Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.
Frye MA; Helleman G; McElroy SL; Altshuler LL; Black DO; Keck PE; Nolen WA; Kupka R; Leverich GS; Grunze H; Mintz J; Post RM; Suppes T
Am J Psychiatry; 2009 Feb; 166(2):164-72. PubMed ID: 19015231
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.
Vieta E; Martinez-Arán A; Goikolea JM; Torrent C; Colom F; Benabarre A; Reinares M
J Clin Psychiatry; 2002 Jun; 63(6):508-12. PubMed ID: 12088162
[TBL] [Abstract][Full Text] [Related]
9. Mania in the Nordic countries: patients and treatment in the acute phase of the EMBLEM study.
Larsen JK; Porsdal V; Aarre TF; Koponen HJ; Aarnio J; Kleivenes OK;
Nord J Psychiatry; 2009; 63(4):285-91. PubMed ID: 19140076
[TBL] [Abstract][Full Text] [Related]
10. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
Sussman N; Mullen J; Paulsson B; Vågerö M
J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
[TBL] [Abstract][Full Text] [Related]
11. Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study.
Rosa AR; Cruz N; Franco C; Haro JM; Bertsch J; Reed C; Aarre TF; Sanchez-Moreno J; Vieta E
J Clin Psychiatry; 2010 Aug; 71(8):1000-6. PubMed ID: 20361912
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for antidepressant-related switch to mania.
Valentí M; Pacchiarotti I; Bonnín CM; Rosa AR; Popovic D; Nivoli AM; Goikolea JM; Murru A; Undurraga J; Colom F; Vieta E
J Clin Psychiatry; 2012 Feb; 73(2):e271-6. PubMed ID: 22401488
[TBL] [Abstract][Full Text] [Related]
13. Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration.
Licht RW; Gijsman H; Nolen WA; Angst J
Acta Psychiatr Scand; 2008 Nov; 118(5):337-46. PubMed ID: 18754834
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants.
Ghaemi SN; Hsu DJ; Thase ME; Wisniewski SR; Nierenberg AA; Miyahara S; Sachs G
Psychiatr Serv; 2006 May; 57(5):660-5. PubMed ID: 16675760
[TBL] [Abstract][Full Text] [Related]
15. Rational polypharmacy in the bipolar affective disorders.
Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
[TBL] [Abstract][Full Text] [Related]
16. Bipolar depression and antidepressant-induced mania: a naturalistic study.
Boerlin HL; Gitlin MJ; Zoellner LA; Hammen CL
J Clin Psychiatry; 1998 Jul; 59(7):374-9. PubMed ID: 9714266
[TBL] [Abstract][Full Text] [Related]
17. Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.
McElroy SL; Suppes T; Frye MA; Altshuler LL; Stanford K; Martens B; Leverich GS; Post RM; Keck PE
J Affect Disord; 2007 Aug; 101(1-3):275-81. PubMed ID: 17229469
[TBL] [Abstract][Full Text] [Related]
18. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
[TBL] [Abstract][Full Text] [Related]
19. Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorder.
Weiser M; Burshtein S; Gershon AA; Marian G; Vlad N; Grecu IG; Tocari E; Tiugan A; Hotineanu M; Davis JM
Bipolar Disord; 2014 Jun; 16(4):441-7. PubMed ID: 24712840
[TBL] [Abstract][Full Text] [Related]
20. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
